HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Failed sclerotherapy trials with the V. spermatica interna. A retrospective analysis in 1141 patients with idiopathic varicocele].

Abstract
From July 1988 until December 1990 1141 patients with left-sided idiopathic varicocele underwent phlebography of the spermatic internal vein, and percutaneous sclerotherapy with sodium morruate (Varicocid) was intended to be performed. In 125 of these patients sclerotherapy was not feasible. The reasons for this were analysed in a retrospective study. According to the anatomical situation of the spermatic vein, there were significant differences in technical success. In case of incompetent valve of the spermatic vein at the renal origin (type I, 2A, 3, 4A), selective probing and following sclerotherapy was possible in 97%. Anatomic variations with competent valve of the spermatic vein (type 0, 2B, 4B) led to difficulties in selectively probing the vessel, and sclerotherapy was feasible in only 72.7%. In these angiographically difficult cases, spasm of the spermatic vein and/or perforation prevented sclerotherapy in 29 of 125 patients.
AuthorsW Bähren, C Biehl, B Danz
JournalRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin (Rofo) Vol. 157 Issue 4 Pg. 355-60 (Oct 1992) ISSN: 1438-9029 [Print] Germany
Vernacular TitleFrustrane Sklerotherapieversuche der V. spermatica interna. Retrospektive Analyse bei 1141 Patienten mit idiopathischer Varikozele.
PMID1391838 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Catheterization, Peripheral (instrumentation, methods)
  • Child
  • Humans
  • Male
  • Middle Aged
  • Radiography
  • Retrospective Studies
  • Sclerotherapy (instrumentation, methods, statistics & numerical data)
  • Spermatic Cord (blood supply)
  • Testis (blood supply)
  • Treatment Failure
  • Varicocele (classification, diagnostic imaging, epidemiology, therapy)
  • Veins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: